Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder

British Journal of Clinical Pharmacology

Volumn 63, Issue 3, 2007, Pages 371-375

  Ilett, Kenneth F ^a,b   Hackett, L Peter ^b   Kristensen, Judith H ^c   Kohan, Rolland ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c Women's and Children's Health Service   (Australia)

Author keywords

Breast milk; Dexamphetamine; Infant dose; Infant well being

Indexed keywords

DEXAMPHETAMINE; PHENTERMINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BREAST FEEDING; BREAST MILK; CASE REPORT; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG MILK LEVEL; DRUG SAFETY; FEMALE; HUMAN; INFANT; MALE; PLASMA; PRIORITY JOURNAL; SHORT COURSE THERAPY;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BREAST FEEDING; DEXTROAMPHETAMINE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; PREGNANCY;

EID: 33847002004     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02767.x     Document Type: Article

References (19)

1. Prince JB. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr Clin N Am 2006; 15: 13-50.
2. Pary R, Lewis S, Matuschka PR, Rudzinskiy P, Safi M, Lippmann S. Attention deficit disorder in adults. Ann Clin Psychiatr 2002; 14: 105-11.
3. Steiner E, Villen T, Hallberg M, Rane A. Amphetamine secretion in breast milk. Eur J Clin Pharmacol 1984; 27: 123-4.
4. The American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776-89 [Review].
5. Hale TW, Ilett KF. Drug Therapy and Breastfeeding. From Theory to Clinical Practice, 1st edn. London: The Parthenon Publishing Group 2002: 1-94.
6. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 7th edn. Philadelphia: Lippincott Williams & Wilkins 2005.
7. Frankenburg WK, Dodds JB. The Denver development screening test. J Pediatr 1967; 71: 181-91.
8. Rossiter EJ. The use of developmental screening and assessment instruments by paediatricians in Australia. J Paediatr Child Health 1993; 29: 357-9.
9. Kristensen JH, Hackett LP, Kohan R, Paech MJ, Ilett KF. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J Hum Lact 2001; 18: 139-43.
10. Begg EJ, Duffull SB, Hackett LP, Ilett KF. Studying drugs in human milk: time to unify the approach. J Hum Lact 2002; 18: 319-28.
11. Bennett PN. Use of the monographs on drugs. In: Drugs and Human Lactation, 2nd edn, ed Bennett PN. Amsterdam: Elsevier 1996: 67-74.
12. Bar-Oz B, Nulman I, Koren G, Ito S. Anticonvulsants and breast feeding: a critical review. Paediatr Drugs 2000; 2: 113-26.
13. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003; 61: S35-S42.
14. Ilett KF, Kristensen JH. Drug use and breastfeeding. Expert Opin Drug Saf 2005; 4: 745-68.
15. Baselt RC. Amphetamine. In: Disposition of Toxic Drugs and Chemicals in Man, edition 6th edn, ed Baselt RC. Foster City, CA: Biomedical Publications 2005: 64-6.
16. Anonymous. SciFinder Scholar. Washington DC: American Chemical Society 2006.
17. Begg EJ. Determinants of drug transfer into human milk. In: Drugs and Human Lactation, edition 2nd edn, ed Bennett PN. Amsterdam: Elsevier 1996: 47-58.
18. Ayd FJ Jr. Excretion of psychotropic drugs in human breast milk. Int Drug Ther News Bull 1973; 8: 33-40.
19. Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, edition 11th edn, eds Brunton LP, Lazo JS, Parket KL. New York: McGraw-Hill 2006: 237-95.